Anti-LGI1-associated cognitive impairment

Neurology

Volumn 87, Issue 8, 2016, Pages 759-765

  Ariño, Helena ^a   Armangué, Thais ^a   Petit Pedrol, Mar ^a   Sabater, Lidia ^a   Martinez Hernandez, Eugenia ^a   Hara, Makoto ^a   Lancaster, Eric ^b   Saiz, Albert ^a   Dalmau, Josep ^a,b,c   Graus, Francesc ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN G4; LEUCINE RICH GLIOMA INACTIVATED 1 ANTIBODY; STEROID; UNCLASSIFIED DRUG; AUTOANTIBODY; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTOR; LGI1 PROTEIN, HUMAN; PROTEIN;

ADULT; AGED; ARTICLE; BRAIN DISEASE; CEREBROSPINAL FLUID; CLINICAL FEATURE; COGNITIVE DEFECT; DISEASE SEVERITY; EVOLUTION; FEMALE; FOLLOW UP; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MENTAL DETERIORATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANEOPLASTIC NEUROPATHY; PLEOCYTOSIS; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; RETURN TO WORK; TREATMENT OUTCOME; BLOOD; BRAIN DISEASES; COGNITIVE DYSFUNCTION; COMBINATION DRUG THERAPY; IMMUNOLOGY; LIMBIC ENCEPHALITIS; MIDDLE AGED; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PROCEDURES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; BRAIN DISEASES; COGNITIVE DYSFUNCTION; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; IMMUNOTHERAPY; LIMBIC ENCEPHALITIS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROTEINS; STEROIDS;

EID: 84983494489     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000003009     Document Type: Article

References (26)

1. Lai M, Huijbers MG, Lancaster E, et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 2010; 9: 776-785.
2. Irani SR, Alexander S, Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-Associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain 2010; 133: 2734-2748.
3. Vincent A, Buckley C, Schott JM, et al. Potassium channel antibody-Associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004; 127: 701-712.
4. Irani SR, Michell AW, Lang B, et al. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol 2011; 69: 892-900.
5. Geschwind MD, Tan KM, Lennon VA, et al. Voltage-gated potassium channel autoimmunity mimicking Creutzfeldt-Jakob disease. Arch Neurol 2008; 65: 1341-1346.
6. Shin YW, Lee ST, Shin JW, et al. VGKC-complex/LGI1-Antibody encephalitis: clinical manifestations and response to immunotherapy. J Neuroimmunol 2013; 265: 75-81.
7. Malter MP, Frisch C, Schoene-Bake JC, et al. Outcome of limbic encephalitis with VGKC-complex antibodies: relation to antigenic specificity. J Neurol 2014; 261: 1695-1705.
8. Gresa-Arribas N, Titulaer MJ, Torrents A, et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol 2014; 13: 167-177.
9. Huijbers MG, Querol LA, Niks EH, et al. The expanding field of IgG4-mediated neurological autoimmune disorders. Eur J Neurol 2015; 22: 1151-1161.
10. Bettcher BM, Gelfand JM, Irani SR, et al. More than memory impairment in voltage-gated potassium channel complex encephalopathy. Eur J Neurol 2014; 21: 1301-1310.
11. Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-Term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013; 12: 157-165.
12. Irani SR, Gelfand JM, Bettcher BM, Singhal NS, Geschwind MD. Effect of rituximab in patients with leucine-rich, glioma-inactivated 1 antibody-Associated encephalopathy. JAMA Neurol 2014; 71: 896-900.
13. Brown JW, Martin PJ, Thorpe JW, et al. Long-Term remission with rituximab in refractory leucine-rich glioma inactivated 1 antibody encephalitis. J Neuroimmunol 2014; 271: 66-68.
14. Cash SS, Larvie M, Dalmau J. Case records of the Massachusetts General Hospital. Case 34-2011: a 75-year-old man with memory loss and partial seizures. N Engl J Med 2011; 365: 1825-1833.
15. Graus F, Titulaer MJ, Balu R, et al. Clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 2016; 15: 391-404.
16. Newey CR, Appleby BS, Shook S, Sarwal A. Patient with voltage-gated potassium-channel (VGKC) limbic encephalitis found to have Creutzfeldt-Jakob disease (CJD) at autopsy. J Neuropsychiatry Clin Neurosci 2013; 25: E05-E07.
17. Angus-Leppan H, Rudge P, Mead S, Collinge J, Vincent A. Autoantibodies in sporadic Creutzfeldt-Jakob disease. JAMA Neurol 2013; 70: 919-922.
18. Grau-Rivera O, Sanchez-Valle R, Saiz A, et al. Determination of neuronal antibodies in suspected and definite Creutzfeldt-Jakob disease. JAMA Neurol 2014; 71: 74-78.
19. Sanchez-Valle R, Nos C, Yague J, Graus F, Dominguez A, Saiz A. Clinical and genetic features of human prion diseases in Catalonia: 1993-2002. Eur J Neurol 2004; 11: 649-655.
20. Tschampa HJ, Kallenberg K, Urbach H, et al. MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease: a study on inter-observer agreement. Brain 2005; 128: 2026-2033.
21. Heine J, Pruss H, Bartsch T, Ploner CJ, Paul F, Finke C. Imaging of autoimmune encephalitis: relevance for clinical practice and hippocampal function. Neuroscience 2015; 309: 68-83.
22. Maat P, de Beukelaar JW, Jansen C, et al. Pathologically confirmed autoimmune encephalitis in suspected Creutzfeldt-Jakob disease. Neurol Neuroimmunol Neuroinflamm 2015; 2: e178.
23. Irani SR, Pettingill P, Kleopa KA, et al. Morvan syndrome: clinical and serological observations in 29 cases. Ann Neurol 2012; 72: 241-255.
24. Ohkawa T, Fukata Y, Yamasaki M, et al. Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors. J Neurosci 2013; 33: 18161-18174.
25. Irani SR, Lehmann-Horn K, Geschwind M, Wang S, Vincent A, von Budingen HC. The active intrathecal Bcell response in LGI1-Antibody encephalitis. Lancet 2015; 385(suppl 1): S46.
26. Niks EH, van Leeuwen Y, Leite MI, et al. Clinical fluctuations in MuSK myasthenia gravis are related to antigenspecific IgG4 instead of IgG1. J Neuroimmunol 2008; 195: 151-156.